{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:41:37Z","timestamp":1794609697504,"version":"4.9.1"},"reference-count":271,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>The Indian Psychiatric Society has previously published guidelines for the management of bipolar disorder (BD) in adults (2017) and children and adolescents (2019). The present guideline summarizes the major advancements in the management of BD since these publications. To make the guideline handier for the clinical practitioner, we have made several structural changes compared to the 2017 guideline. First: we have adopted a phase-specific approach with different sections and management algorithms for each major phase of BD (mania, depression, and mixed episodes in bipolar type I disorder [BD-I] and depression in bipolar type II disorder [BD-II]). Second: for better clarity and ease of adoption, we have structured our suggestions into first, second, and third-line treatments; these rankings are based on the composite of evidence, experience, and consensus ratings of efficacy, tolerability, availability, and affordability. Third: a separate section for BD-II disorder has been added, given its relatively high prevalence in the Indian setting. Fourth: we have added a detailed section on special treatment considerations, where practical issues such as the management of comorbidities, treatment adherence, the role of polypharmacy, clozapine, emerging treatments, and long-acting injectables, as well as the reproductive safety of medications in BD, are discussed. Finally, we have added an expert consensus section where we present our consensus opinions on common dilemmas in the management of BD. We liberally use tables and flowcharts to enhance understanding and uptake of the suggestions offered. We hope these guidelines promote evidence-informed decision-making in the management of BD.<\/jats:p>","DOI":"10.4103\/indianjpsychiatry_1186_25","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:00:34Z","timestamp":1769508034000},"page":"8-43","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Clinical practice guidelines for the management of bipolar disorder: 2025 update"],"prefix":"10.4103","volume":"68","author":[{"given":"Vikas","family":"Menon","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragul","family":"Ganesh","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Deep","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujit","family":"Sarkhel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Institute of Psychiatry, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santanu","family":"Goswami","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Manipal Hospital, Salt Lake, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debadatta","family":"Mohapatra","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra Neelakanthappa","family":"Munoli","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Podila Satya Venkata Narasimha","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MS","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, ASHA Bipolar Clinic, ASHA Hospitals, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kesavan","family":"Muralidharan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"Suppl 1","key":"R1-20260420","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.4103\/0019-5545.196974","article-title":"Clinical practice guidelines for management of bipolar disorder","volume":"59","author":"Shah","year":"2017","journal-title":"Indian J Psychiatry"},{"issue":"Suppl 2","key":"R2-20260420","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4103\/psychiatry.IndianJPsychiatry_570_18","article-title":"Clinical practice guidelines for bipolar affective disorder (BPAD) in children and adolescents","volume":"61","author":"Gautam","year":"2019","journal-title":"Indian J Psychiatry"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_838_23","article-title":"Bipolar affective disorder in India: A multi-site population-based cross-sectional study","volume":"65","author":"Vajawat","year":"2023","journal-title":"Indian J Psychiatry"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jad.2019.07.054","article-title":"Conventional mood stabilizers and\/or second-generation antipsychotic drugs in bipolar disorders: A population-based comparison of risk of treatment failure","volume":"257","author":"Tournier","year":"2019","journal-title":"J Affect Disord"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1176\/appi.ajp.157.11.1873","article-title":"Development and validation of a screening instrument for bipolar spectrum disorder: The mood disorder questionnaire","volume":"157","author":"Hirschfeld","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0165-0327(03)00196-4","article-title":"Sensitivity and specificity of a new bipolar spectrum diagnostic scale","volume":"84","author":"Nassir Ghaemi","year":"2005","journal-title":"J Affect Disord"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archpsyc.1987.01800180050009","article-title":"The longitudinal interval follow-up evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies","volume":"44","author":"Keller","year":"1987","journal-title":"Arch Gen Psychiatry"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jad.2010.02.118","article-title":"A population-based analysis of distinguishers of bipolar disorder from major depressive disorder","volume":"125","author":"Schaffer","year":"2010","journal-title":"J Affect Disord"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/08039488.2022.2083231","article-title":"Factors associated with lifetime suicide attempts: Findings from the bipolar disorder course and outcome study from India (BiD-CoIN study)","volume":"77","author":"Grover","year":"2023","journal-title":"Nord J Psychiatry"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ajp.2013.07.005","article-title":"Suicide risk assessment and formulation: An update","volume":"6","author":"Menon","year":"2013","journal-title":"Asian J Psychiatry"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1017\/S0033291799002810","article-title":"Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness","volume":"30","author":"Denicoff","year":"2000","journal-title":"Psychol Med"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4103\/0253-7176.101767","article-title":"Metabolic syndrome in bipolar disorders","volume":"34","author":"Grover","year":"2012","journal-title":"Indian J Psychol Med"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1038\/s41380-023-02109-9","article-title":"All-cause and cause-specific mortality among people with bipolar disorder: A large-scale systematic review and meta-analysis","volume":"28","author":"Biazus","year":"2023","journal-title":"Mol Psychiatry"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1192\/bjp.138.4.332","article-title":"The burden on the family of a psychiatric patient: Development of an interview schedule","volume":"138","author":"Pai","year":"1981","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"R15-20260420","first-page":"21","article-title":"Instrument to assess burden on caregivers of chronic mentally ill","volume":"40","author":"Thara","year":"1998","journal-title":"Indian J Psychiatry"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00127-007-0242-8","article-title":"Caregiver burden and coping: A prospective study of relationship between burden and coping in caregivers of patients with schizophrenia and bipolar affective disorder","volume":"42","author":"Chadda","year":"2007","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1399-5618.2011.00942.x","article-title":"Development of guidelines for caregivers of people with bipolar disorder: A Delphi expert consensus study","volume":"13","author":"Berk","year":"2011","journal-title":"Bipolar Disord"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"165","DOI":"10.31887\/DCNS.2008.10.2\/evieta","article-title":"Acute and long-term treatment of mania","volume":"10","author":"Vieta","year":"2008","journal-title":"Dialogues Clin Neurosci"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/YCO.0000000000000787","article-title":"Psychopharmacology of agitation in acute psychotic and manic episodes","volume":"35","author":"Stetson","year":"2022","journal-title":"Curr Opin Psychiatry"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord"},{"issue":"Suppl 5","key":"R21-20260420","first-page":"9","article-title":"Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder","volume":"69","author":"Ketter","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 1","key":"R22-20260420","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000068020","article-title":"Initial lithium and valproate combination therapy in acute mania","volume":"46","author":"Reischies","year":"2002","journal-title":"Neuropsychobiology"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-2002-36392","article-title":"Initial triple therapy of acute mania, adding lithium and valproate to neuroleptics","volume":"35","author":"Reischies","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/YCT.0b013e3181624b5d","article-title":"Bifrontal versus bitemporal electroconvulsive therapy in severe manic patients","volume":"24","author":"Barekatain","year":"2008","journal-title":"J ECT"},{"key":"R25-20260420","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1399-5618.2008.00608.x","article-title":"Double-blind randomized controlled study comparing short-term efficacy of bifrontal and bitemporal electroconvulsive therapy in acute mania","volume":"10","author":"Hiremani","year":"2008","journal-title":"Bipolar Disord"},{"key":"R26-20260420","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jad.2008.12.020","article-title":"Efficacy of high frequency (rapid) suprathreshold repetitive transcranial magnetic stimulation of right prefrontal cortex in bipolar mania: A randomized sham controlled study","volume":"117","author":"Praharaj","year":"2009","journal-title":"J Affect Disord"},{"key":"R27-20260420","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/bdi.13283","article-title":"Brain stimulation treatment for bipolar disorder","volume":"25","author":"Mutz","year":"2023","journal-title":"Bipolar Disord"},{"key":"R28-20260420","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.4088\/JCP.13r08905","article-title":"Rapid cycling in bipolar disorder: A systematic review","volume":"75","author":"Carvalho","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"R29-20260420","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/0269905031000070170","article-title":"Rapid cycling bipolar disorder after left temporal polar damage","volume":"17","author":"Murai","year":"2003","journal-title":"Brain Inj"},{"key":"R30-20260420","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bdi.12288","article-title":"Risk factors for rapid cycling in bipolar disorder","volume":"17","author":"Valent\u00ed","year":"2015","journal-title":"Bipolar Disord"},{"key":"R31-20260420","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1399-5618.2009.00713.x","article-title":"Pharmacologic treatment of rapid cycling and mixed states in bipolar disorder: An argument for the use of lithium","volume":"11","author":"Muzina","year":"2009","journal-title":"Bipolar Disord"},{"key":"R32-20260420","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jad.2025.02.025","article-title":"Factors associated with lifetime rapid cycling in bipolar disorder: Findings from the Bipolar Disorder Course and Outcome study from India (BiD-CoIN study)","volume":"378","author":"Grover","year":"2025","journal-title":"J Affect Disord"},{"key":"R33-20260420","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1192\/pb.bp.116.054031","article-title":"Drug information update. Lithium and chronic kidney disease: Debates and dilemmas","volume":"41","author":"Gupta","year":"2017","journal-title":"BJPsych Bull"},{"key":"R35-20260420","doi-asserted-by":"crossref","first-page":"815","DOI":"10.4088\/JCP.v60n1202","article-title":"Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients","volume":"60","author":"Hirschfeld","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R36-20260420","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4088\/JCP.v64n0717","article-title":"The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder","volume":"64","author":"Hirschfeld","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R37-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-1211(02)00007-4","article-title":"Comparison of the bioavailability of unequal doses of divalproex sodium extended-release formulation relative to the delayed-release formulation in healthy volunteers","volume":"49","author":"Dutta","year":"2002","journal-title":"Epilepsy Res"},{"key":"R38-20260420","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","article-title":"Valproate: Past, present, and future","volume":"9","author":"Johannessen","year":"2003","journal-title":"CNS Drug Rev"},{"key":"R39-20260420","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1176\/appi.ajp.163.2.272","article-title":"Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania","volume":"163","author":"Allen","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R40-20260420","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.paed.2025.02.005","article-title":"Beyond valproate: Considerations for the general paediatrician","volume":"35","author":"Skippen","year":"2025","journal-title":"Paediatr Child Health"},{"key":"R42-20260420","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11920-025-01606-8","article-title":"Global Trends in the Use of Pharmacotherapy for the Treatment of Bipolar Disorder","volume":"27","author":"Yocum","year":"2025","journal-title":"Curr Psychiatry Rep"},{"key":"R43-20260420","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/bdi.13366","article-title":"Patterns of pharmacotherapy for bipolar disorder: A GBC survey","volume":"26","author":"Singh","year":"2024","journal-title":"Bipolar Disord"},{"key":"R44-20260420","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2147\/TCRM.S131021","article-title":"Collaboration in pharmacovigilance: Lamotrigine and fatal severe cutaneous adverse reactions \u2013 A review of spontaneous reports","volume":"13","author":"Brickel","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"R45-20260420","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1345\/aph.18422","article-title":"Factors influencing the incidence of lamotrigine-related skin rash","volume":"33","author":"Wong","year":"1999","journal-title":"Ann Pharmacother"},{"key":"R46-20260420","first-page":"463","article-title":"The role of lamotrigine in the management of bipolar disorder","volume":"3","author":"Ng","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R48-20260420","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/epi4.12495","article-title":"A new rapid titration protocol for lamotrigine that reduces the risk of skin rash","volume":"6","author":"Jang","year":"2021","journal-title":"Epilepsia Open"},{"key":"R49-20260420","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1515\/CCLM.2004.245","article-title":"Therapeutic drug monitoring of old and newer anti-epileptic drugs","volume":"42","author":"Neels","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"R50-20260420","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/ipj.ipj_3_19","article-title":"Effect size of lithium, carbamazepine, and sodium valproate in child and adolescent bipolar 1 disorder during manic phase: A prospective open-label study","volume":"28","author":"Singh","year":"2019","journal-title":"Ind Psychiatry J"},{"key":"R51-20260420","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/JCP.0b13e318033bd5e","article-title":"Management of acute agitation in patients with bipolar disorder: Efficacy and safety of intramuscular aripiprazole","volume":"27","author":"Zimbroff","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R52-20260420","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00004714-200108000-00006","article-title":"A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania","volume":"21","author":"Meehan","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R53-20260420","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/0004867419826718","article-title":"Prescribing practices of Indian psychiatrists in the treatment of bipolar disorder","volume":"53","author":"Reddy","year":"2019","journal-title":"Aust N Z J Psychiatry"},{"key":"R54-20260420","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1177\/0091270009347870","article-title":"Efficacy of sodium valproate and haloperidol in the management of acute mania: A randomized open-label comparative study","volume":"50","author":"Sekhar","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"R55-20260420","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/0019-5545.31603","article-title":"Efficacy and tolerability of injectable sodium valproate in patients with mania","volume":"48","author":"Solanki","year":"2006","journal-title":"Indian J Psychiatry"},{"key":"R56-20260420","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/JCP.0000000000001064","article-title":"Efficacy and safety of asenapine versus olanzapine in combination with divalproex for acute mania: A randomized controlled trial","volume":"39","author":"Mahajan","year":"2019","journal-title":"J Clin Psychopharmacol"},{"key":"R57-20260420","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4103\/0019-5545.196708","article-title":"Distressing cutaneous lesion among bipolar affective disorder patients on lithium therapy: A retrospective cross-sectional study","volume":"58","author":"Ummar","year":"2016","journal-title":"Indian J Psychiatry"},{"key":"R58-20260420","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4103\/IJPSYM.IJPSYM_87_17","article-title":"Prevalence and sociodemographic profile of lithium-induced cutaneous side effects in bipolar affective disorder patients: A 1-year prospective observational study in South India","volume":"39","author":"Suganya Priyadharshini","year":"2017","journal-title":"Indian J Psychol Med"},{"key":"R59-20260420","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/bdi.13276","article-title":"Effect of regulated add-on sodium chloride intake on stabilization of serum lithium concentration in bipolar disorder: A randomized controlled trial","volume":"25","author":"George","year":"2023","journal-title":"Bipolar Disord"},{"key":"R60-20260420","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/cts.12407","article-title":"Endoxifen, a new treatment option for mania: A double-blind, active-controlled trial demonstrates the antimanic efficacy of endoxifen","volume":"9","author":"Ahmad","year":"2016","journal-title":"Clin Transl Sci"},{"key":"R61-20260420","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/bdi.13041","article-title":"Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder","volume":"23","author":"Ahmad","year":"2021","journal-title":"Bipolar Disord"},{"key":"R62-20260420","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4103\/psychiatry.IndianJPsychiatry_339_19","article-title":"Assessment of lithium-related knowledge and attitudes among patients with bipolar disorder on long-term lithium maintenance treatment","volume":"62","author":"Kumar","year":"2020","journal-title":"Indian J Psychiatry"},{"key":"R63-20260420","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ajp.2019.09.015","article-title":"Self-reported medication adherence and its correlates in a lithium-maintained cohort with bipolar disorder at a tertiary care center in India","volume":"46","author":"Singh","year":"2019","journal-title":"Asian J Psychiatry"},{"issue":"Suppl 1","key":"R64-20260420","doi-asserted-by":"crossref","first-page":"S355","DOI":"10.4103\/0019-5545.69265","article-title":"Research on mood stabilizers in India","volume":"52","author":"Avasthi","year":"2010","journal-title":"Indian J Psychiatry"},{"key":"R65-20260420","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.187.3.229","article-title":"Risperidone in the treatment of acute mania: Double-blind, placebo-controlled study","volume":"187","author":"Khanna","year":"2005","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"R66-20260420","first-page":"160","article-title":"Four year follow-up of first episode manic patients","volume":"39","author":"Khess","year":"1997","journal-title":"Indian J Psychiatry"},{"key":"R67-20260420","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0019-5545.94644","article-title":"Clinical profile and outcome of bipolar disorder patients receiving electroconvulsive therapy: A study from north India","volume":"54","author":"Bharadwaj","year":"2012","journal-title":"Indian J Psychiatry"},{"issue":"Suppl 3","key":"R68-20260420","first-page":"S571","article-title":"Profile of patients with Bipolar affective disorder receiving ECT","volume":"64","author":"Kohat","year":"2022","journal-title":"Indian J Psychiatry"},{"key":"R69-20260420","doi-asserted-by":"crossref","first-page":"245","DOI":"10.9758\/cpn.2015.13.3.245","article-title":"Efficacy of adjunctive high frequency repetitive transcranial magnetic stimulation of right prefrontal cortex in adolescent mania: A randomized sham-controlled study","volume":"13","author":"Pathak","year":"2015","journal-title":"Clin Psychopharmacol Neurosci Off Sci J Korean Coll Neuropsychopharmacol"},{"key":"R70-20260420","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_698_23","article-title":"Research on clinical aspects of bipolar disorder: A review of Indian studies","volume":"66","author":"Narula","year":"2024","journal-title":"Indian J Psychiatry"},{"key":"R71-20260420","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eurpsy.2004.12.002","article-title":"The treatment of mixed states and the risk of switching to depression","volume":"20","author":"Vieta","year":"2005","journal-title":"Eur Psychiatry"},{"key":"R72-20260420","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1176\/appi.ajp.2008.08030322","article-title":"Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression","volume":"166","author":"Frye","year":"2009","journal-title":"Am J Psychiatry"},{"key":"R73-20260420","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-5618.2006.00348.x","article-title":"Antidepressants and suicidal behavior in bipolar disorder","volume":"8","author":"McElroy","year":"2006","journal-title":"Bipolar Disord"},{"key":"R74-20260420","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bdi.13135","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations","volume":"23","author":"Yatham","year":"2021","journal-title":"Bipolar Disord"},{"key":"R75-20260420","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bdi.12850","article-title":"Cariprazine in the treatment of bipolar disorder: A systematic review and meta-analysis","volume":"22","author":"Pinto","year":"2020","journal-title":"Bipolar Disord"},{"key":"R76-20260420","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jad.2019.07.020","article-title":"Cariprazine for the treatment of bipolar mania with mixed features: A post hoc pooled analysis of 3 trials","volume":"257","author":"McIntyre","year":"2019","journal-title":"J Affect Disord"},{"key":"R77-20260420","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1017\/S1092852917000074","article-title":"Lurasidone for major depressive disorder with mixed features and anxiety: A post-hoc analysis of a randomized, placebo-controlled study","volume":"22","author":"Tsai","year":"2017","journal-title":"CNS Spectr"},{"key":"R78-20260420","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/15622975.2017.1384850","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: Acute and long-term treatment of mixed states in bipolar disorder","volume":"19","author":"Grunze","year":"2018","journal-title":"World J Biol Psychiatry"},{"key":"R79-20260420","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/JCP.0000000000001964","article-title":"Lumateperone for the treatment of major depressive disorder with mixed features or bipolar depression with mixed features: A randomized placebo-controlled trial","volume":"45","author":"Durgam","year":"2025","journal-title":"J Clin Psychopharmacol"},{"key":"R80-20260420","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archpsyc.1997.01830130041008","article-title":"Depression during mania. Treatment response to lithium or divalproex","volume":"54","author":"Swann","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"R81-20260420","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00023210-200620030-00004","article-title":"Extended-release carbamazepine capsules as monotherapy in bipolar disorder: Pooled results from two randomized, double-blind, placebo-controlled trials","volume":"20","author":"Weisler","year":"2006","journal-title":"CNS Drugs"},{"issue":"Suppl 5","key":"R82-20260420","first-page":"5","article-title":"The impact of bipolar depression","volume":"66","author":"Post","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R83-20260420","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2215-0366(14)70314-1","article-title":"Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: A systematic review and network meta-analysis","volume":"1","author":"Miura","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"R84-20260420","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S2215-0366(23)00199-2","article-title":"Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: A systematic review and network meta-analysis","volume":"10","author":"Yildiz","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"R85-20260420","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/15622970903555881","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: Update 2010 on the treatment of acute bipolar depression","volume":"11","author":"Grunze","year":"2010","journal-title":"World J Biol Psychiatry"},{"key":"R86-20260420","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/2349-4220.134448","article-title":"Anti-depressants in bipolar disorder: Quo vadimus?","volume":"1","author":"Menon","year":"2014","journal-title":"Int J Adv Med Health Res"},{"key":"R87-20260420","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40345-018-0133-9","article-title":"Antidepressants in bipolar depression: An enduring controversy","volume":"6","author":"Gitlin","year":"2018","journal-title":"Int J Bipolar Disord"},{"key":"R88-20260420","doi-asserted-by":"crossref","first-page":"20451253231202723","DOI":"10.1177\/20451253231202723","article-title":"Ketamine for bipolar depression: An updated systematic review","volume":"13","author":"Fancy","year":"2023","journal-title":"Ther Adv Psychopharmacol"},{"key":"R89-20260420","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4103\/0253-7613.161277","article-title":"Ketamine-induced affective switch in a patient with treatment-resistant depression","volume":"47","author":"Banwari","year":"2015","journal-title":"Indian J Pharmacol"},{"key":"R90-20260420","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3389\/fpsyt.2020.00516","article-title":"Affective switch associated with oral, low dose ketamine treatment in a patient with treatment resistant bipolar I depression. Case report and literature review","volume":"11","author":"Wilkowska","year":"2020","journal-title":"Front Psychiatry"},{"key":"R91-20260420","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/ijms17020241","article-title":"Atypical antipsychotics in the treatment of acute bipolar depression with mixed features: A systematic review and exploratory meta-analysis of placebo-controlled clinical trials","volume":"17","author":"Fornaro","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R92-20260420","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1176\/appi.ajp.2015.15060770","article-title":"Lurasidone for the Treatment of major depressive disorder with mixed features: A randomized, double-blind, placebo-controlled study","volume":"173","author":"Suppes","year":"2016","journal-title":"Am J Psychiatry"},{"key":"R93-20260420","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jad.2015.04.054","article-title":"Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trial","volume":"184","author":"El-Mallakh","year":"2015","journal-title":"J Affect Disord"},{"key":"R94-20260420","doi-asserted-by":"crossref","first-page":"102549","DOI":"10.1016\/j.ajp.2021.102549","article-title":"Prescription patterns in clinically stable patients with bipolar disorder: Findings from the Bipolar Disorder Course and Outcome from India (BiD-CoIN) study","volume":"57","author":"Grover","year":"2021","journal-title":"Asian J Psychiatry"},{"key":"R95-20260420","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jad.2020.07.066","article-title":"Antidepressant effects of ketamine and ECT: A pilot comparison","volume":"276","author":"Sharma","year":"2020","journal-title":"J Affect Disord"},{"key":"R96-20260420","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/0253-7176.85393","article-title":"Repetitive transcranial magnetic stimulation in the treatment of depression: A randomized, double-blind, placebo-controlled Trial","volume":"33","author":"Lingeswaran","year":"2011","journal-title":"Indian J Psychol Med"},{"key":"R97-20260420","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jad.2010.06.027","article-title":"Efficacy of adjunctive high frequency repetitive transcranial magnetic stimulation of left prefrontal cortex in depression: A randomized sham controlled study","volume":"128","author":"Ray","year":"2011","journal-title":"J Affect Disord"},{"key":"R98-20260420","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/YCT.0000000000000870","article-title":"Safety and efficacy of continuous theta burst \u201cintensive\u201d stimulation in acute-phase bipolar depression: A pilot, exploratory study","volume":"39","author":"Mallik","year":"2023","journal-title":"J ECT"},{"key":"R99-20260420","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJMoa2300184","article-title":"Duration of adjunctive antidepressant maintenance in bipolar I depression","volume":"389","author":"Yatham","year":"2023","journal-title":"N Engl J Med"},{"key":"R100-20260420","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"R101-20260420","doi-asserted-by":"crossref","first-page":"e1259","DOI":"10.4088\/JCP.16r11165","article-title":"Review and meta-analysis of epidemiologic studies of adult bipolar disorder","volume":"78","author":"Moreira","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"R102-20260420","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_499_24","article-title":"A comparison of demographic profiles, clinical profile, course, and outcome of Bipolar I Disorder and Bipolar II Disorder: Findings from the Bipolar Disorder Course and Outcome study from India (BiD-CoIN study)","volume":"66","author":"Grover","year":"2024","journal-title":"Indian J Psychiatry"},{"key":"R103-20260420","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/bdi.13378","article-title":"Multi-trial, aggregated, individual participant data mega-analysis of short-term antidepressant versus mood stabilizer monotherapy of bipolar type II major depressive episode","volume":"26","author":"Amsterdam","year":"2024","journal-title":"Bipolar Disord"},{"key":"R104-20260420","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1176\/appi.ajp.2021.20091339","article-title":"Efficacy and safety of lumateperone for major depressive episodes associated with bipolar I or bipolar II disorder: A phase 3 randomized placebo-controlled trial","volume":"178","author":"Calabrese","year":"2021","journal-title":"Am J Psychiatry"},{"key":"R105-20260420","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.euroneuro.2022.12.012","article-title":"The efficacy of lumateperone on symptoms of depression in bipolar I and bipolar II disorder: Secondary and post hoc analyses","volume":"68","author":"McIntyre","year":"2023","journal-title":"Eur Neuropsychopharmacol"},{"key":"R108-20260420","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/bdi.12287","article-title":"Psychoeducation for relapse prevention in bipolar disorder: A systematic review of efficacy in randomized controlled trials","volume":"17","author":"Bond","year":"2015","journal-title":"Bipolar Disord"},{"key":"R109-20260420","doi-asserted-by":"crossref","first-page":"17r11750","DOI":"10.4088\/JCP.17r11750","article-title":"Randomized controlled trials of psychoeducation modalities in the management of bipolar disorder: A systematic review","volume":"79","author":"Soo","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"R110-20260420","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-0327(01)00460-8","article-title":"Psychoeducational and cognitive-behavioral strategies in the management of bipolar disorder","volume":"73","author":"Otto","year":"2003","journal-title":"J Affect Disord"},{"key":"R111-20260420","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/archpsyc.60.2.145","article-title":"A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: Outcome of the first year","volume":"60","author":"Lam","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R112-20260420","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1176\/appi.focus.20190004","article-title":"Evidence-based psychotherapies for bipolar disorder","volume":"17","author":"Novick","year":"2019","journal-title":"Focus"},{"key":"R113-20260420","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archpsyc.62.9.996","article-title":"Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder","volume":"62","author":"Frank","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R114-20260420","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11920-016-0712-3","article-title":"Social rhythm therapies for mood disorders: An update","volume":"18","author":"Haynes","year":"2016","journal-title":"Curr Psychiatry Rep"},{"key":"R115-20260420","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/archpsyc.60.9.904","article-title":"A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder","volume":"60","author":"Miklowitz","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R117-20260420","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1037\/0022-006X.68.4.615","article-title":"Prevention of relapse\/recurrence in major depression by mindfulness-based cognitive therapy","volume":"68","author":"Teasdale","year":"2000","journal-title":"J Consult Clin Psychol"},{"key":"R118-20260420","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jad.2017.08.025","article-title":"The effectiveness of adjunct mindfulness-based intervention in treatment of bipolar disorder: A systematic review and meta-analysis","volume":"225","author":"Chu","year":"2018","journal-title":"J Affect Disord"},{"key":"R119-20260420","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/acps.12033","article-title":"A randomized controlled trial of mindfulness-based cognitive therapy for bipolar disorder","volume":"127","author":"Perich","year":"2013","journal-title":"Acta Psychiatr Scand"},{"key":"R120-20260420","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jad.2016.03.004","article-title":"Exercise in bipolar patients: A systematic review","volume":"198","author":"Melo","year":"2016","journal-title":"J Affect Disord"},{"key":"R121-20260420","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1590\/2237-6089-2015-0006","article-title":"A systematic review of cognitive rehabilitation for bipolar disorder","volume":"37","author":"Kluwe-Schiavon","year":"2015","journal-title":"Trends Psychiatry Psychother"},{"key":"R122-20260420","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1192\/bjp.bp.114.162123","article-title":"Functional remediation in bipolar disorder: 1-year follow-up ofneurocognitive and functional outcome","volume":"208","author":"Bonnin","year":"2016","journal-title":"Br J Psychiatry"},{"key":"R123-20260420","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1399-5618.2009.00716.x","article-title":"Identifying and treating cognitive impairment in bipolar disorder","volume":"11","author":"Goldberg","year":"2009","journal-title":"Bipolar Disord"},{"key":"R124-20260420","first-page":"199","article-title":"Effect of psycho-education on Knowledge, Attitude and Burden among caregivers of persons with bipolar disorder \u2013 randomized controlled trial","volume":"3","author":"George","year":"2015","journal-title":"Int J Adv Res"},{"key":"R125-20260420","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_445_24","article-title":"Efficacy of brief cognitive behavior therapy in improving symptoms, functioning, and adherence to treatment in patients with bipolar disorder in remission: A randomized control study","volume":"66","author":"Nambiar","year":"2024","journal-title":"Indian J Psychiatry"},{"key":"R126-20260420","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/0253717620950253","article-title":"Family focused therapy for family members of patients with bipolar disorder: Case reports of its impact on expressed emotions","volume":"43","author":"Padmavathi","year":"2021","journal-title":"Indian J Psychol Med"},{"key":"R127-20260420","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1176\/foc.1.1.64","article-title":"Practice guideline for the treatment of patients with bipolar disorder (Revision)","volume":"1","author":"Hirschfeld","year":"2003","journal-title":"Focus"},{"key":"R128-20260420","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.euroneuro.2015.07.013","article-title":"Recurrence rates in bipolar disorder: Systematic comparison of long-term prospective, naturalistic studies versus randomized controlled trials","volume":"25","author":"V\u00e1zquez","year":"2015","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"R129-20260420","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1399-5618.2007.00389.x","article-title":"Continuation versus discontinuation of lithium in recurrent bipolar illness: A naturalistic study","volume":"9","author":"Biel","year":"2007","journal-title":"Bipolar Disord"},{"key":"R130-20260420","doi-asserted-by":"crossref","DOI":"10.1177\/02537176251313523","article-title":"Lifelong pharmacoprophylaxis in bipolar disorder: Holy grail or hollow promise?","author":"Grover","year":"2025","journal-title":"Indian J Psychol Med"},{"key":"R131-20260420","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/JCP.0000000000000160","article-title":"Outcome of mood stabilizer discontinuation in bipolar disorder after 5 years of euthymia","volume":"34","author":"Sharma","year":"2014","journal-title":"J Clin Psychopharmacol"},{"key":"R132-20260420","doi-asserted-by":"crossref","first-page":"e087999","DOI":"10.1136\/bmjopen-2024-087999","article-title":"The efficacy of valproate in acute mania, bipolar depression and maintenance therapy for bipolar disorder: An overview of systematic reviews with meta-analyses","volume":"14","author":"Mari","year":"2024","journal-title":"BMJ Open"},{"key":"R133-20260420","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1176\/appi.ajp.2017.16040419","article-title":"Randomized, double-blind, placebo-controlled trial of asenapine maintenance therapy in adults with an acute manic or mixed episode associated with bipolar I disorder","volume":"175","author":"Szegedi","year":"2018","journal-title":"Am J Psychiatry"},{"key":"R134-20260420","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4088\/JCP.v68n1003","article-title":"Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: A 100-week, double-blind study versus placebo","volume":"68","author":"Keck","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R135-20260420","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.ajp.163.2.247","article-title":"Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine","volume":"163","author":"Tohen","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R136-20260420","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.euroneuro.2012.03.004","article-title":"A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder","volume":"22","author":"Vieta","year":"2012","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"R137-20260420","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/mp.2015.158","article-title":"Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial","volume":"21","author":"Yatham","year":"2016","journal-title":"Mol Psychiatry"},{"key":"R138-20260420","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40345-024-00345-8","article-title":"Lithium and its effects: Does dose matter?","volume":"12","author":"Manchia","year":"2024","journal-title":"Int J Bipolar Disord"},{"key":"R139-20260420","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/bdi.12714","article-title":"Delphi survey of maintenance lithium treatment in older adults with bipolar disorder: An ISBD task force report","volume":"21","author":"Shulman","year":"2019","journal-title":"Bipolar Disord"},{"key":"R140-20260420","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0165-0327(99)00149-4","article-title":"Venlafaxine monotherapy in women with bipolar II and unipolar major depression","volume":"59","author":"Amsterdam","year":"2000","journal-title":"J Affect Disord"},{"key":"R141-20260420","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1176\/appi.ajp.2009.09020284","article-title":"Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: A randomized, double-blind, placebo-substitution study","volume":"167","author":"Amsterdam","year":"2010","journal-title":"Am J Psychiatry"},{"key":"R142-20260420","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5498\/wjp.v8.i5.114","article-title":"Treatment alliance and adherence in bipolar disorder","volume":"8","author":"Chakrabarti","year":"2018","journal-title":"World J Psychiatry"},{"key":"R143-20260420","doi-asserted-by":"crossref","first-page":"168","DOI":"10.9758\/cpn.2018.16.2.168","article-title":"A cross-sectional analysis of patterns and predictors of medication adherence in bipolar disorder: Single center experience from South India","volume":"16","author":"Selvakumar","year":"2018","journal-title":"Clin Psychopharmacol Neurosci Off Sci J Korean Coll Neuropsychopharmacol"},{"key":"R144-20260420","doi-asserted-by":"crossref","first-page":"506","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_249_22","article-title":"Medication nonadherence and its associated factors in psychiatric patients in India: A systematic review and meta-analysis","volume":"65","author":"Ramamurthy","year":"2023","journal-title":"Indian J Psychiatry"},{"key":"R145-20260420","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00406-009-0085-2","article-title":"Duration of untreated illness and suicide in bipolar disorder: A naturalistic study","volume":"260","author":"Altamura","year":"2010","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R146-20260420","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jad.2016.01.002","article-title":"Improving medication adherence in bipolar disorder: A systematic review and meta-analysis of 30 years of intervention trials","volume":"194","author":"MacDonald","year":"2016","journal-title":"J Affect Disord"},{"key":"R147-20260420","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","article-title":"Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology","volume":"30","author":"Goodwin","year":"2016","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"R148-20260420","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5498\/wjp.v6.i4.399","article-title":"Treatment-adherence in bipolar disorder: A patient-centred approach","volume":"6","author":"Chakrabarti","year":"2016","journal-title":"World J Psychiatry"},{"key":"R149-20260420","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpsychires.2018.07.013","article-title":"Therapeutic effects of mobile-based text message reminders for medication adherence in bipolar I disorder: Are they maintained after intervention cessation?","volume":"104","author":"Menon","year":"2018","journal-title":"J Psychiatr Res"},{"key":"R150-20260420","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.genhosppsych.2019.11.004","article-title":"Telemedicine interventions for medication adherence in mental illness: A systematic review","volume":"62","author":"Basit","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"key":"R151-20260420","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14656566.2024.2329743","article-title":"Long-acting second-generation injectable antipsychotics for the maintenance treatment of bipolar disorder: A narrative review","volume":"25","author":"Belge","year":"2024","journal-title":"Expert Opin Pharmacother"},{"key":"R152-20260420","doi-asserted-by":"crossref","first-page":"115676","DOI":"10.1016\/j.psychres.2023.115676","article-title":"Impact of long-acting injectable antipsychotics vs. oral medication on relapses of patients with psychosis and bipolar disorder","volume":"332","author":"Vgontzas","year":"2024","journal-title":"Psychiatry Res"},{"key":"R153-20260420","doi-asserted-by":"crossref","first-page":"104338","DOI":"10.1016\/j.ajp.2024.104338","article-title":"Long-acting injectable antipsychotic use in patients with bipolar disorder: Findings from the REAP-BD study","volume":"103","author":"Lin","year":"2025","journal-title":"Asian J Psychiatry"},{"key":"R154-20260420","doi-asserted-by":"crossref","first-page":"121","DOI":"10.9758\/cpn.2015.13.2.121","article-title":"A systemic review and experts\u2019 consensus for long-acting injectable antipsychotics in bipolar disorder","volume":"13","author":"Chou","year":"2015","journal-title":"Clin Psychopharmacol Neurosci Off Sci J Korean Coll Neuropsychopharmacol"},{"key":"R155-20260420","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4088\/JCP.16m11201","article-title":"Efficacy and safety of aripiprazole once-monthly in the maintenance treatment of bipolar I disorder: A double-blind, placebo-controlled, 52-week randomized withdrawal study","volume":"78","author":"Calabrese","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"R156-20260420","doi-asserted-by":"crossref","first-page":"20r13263","DOI":"10.4088\/JCP.20r13263","article-title":"A systematic review of complex polypharmacy in bipolar disorder: Prevalence, clinical features, adherence, and preliminary recommendations for practitioners","volume":"82","author":"Kim","year":"2021","journal-title":"J Clin Psychiatry"},{"key":"R157-20260420","doi-asserted-by":"crossref","first-page":"61","DOI":"10.9758\/cpn.2022.20.1.61","article-title":"Prescription patterns for bipolar disorder in Asian countries: Findings from research on Asian prescription pattern-bipolar disorder","volume":"20","author":"Lin","year":"2022","journal-title":"Clin Psychopharmacol Neurosci Off Sci J Korean Coll Neuropsychopharmacol"},{"key":"R158-20260420","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jad.2019.06.050","article-title":"Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors","volume":"257","author":"Fung","year":"2019","journal-title":"J Affect Disord"},{"key":"R159-20260420","first-page":"153","article-title":"Rational polypharmacy in the bipolar affective disorders","volume":"11","author":"Post","year":"1996","journal-title":"Epilepsy Res Suppl"},{"key":"R160-20260420","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/acps.13312","article-title":"Polypharmacy as maintenance treatment in bipolar illness: A systematic review","volume":"144","author":"Amerio","year":"2021","journal-title":"Acta Psychiatr Scand"},{"key":"R161-20260420","first-page":"e70004","article-title":"Adjunctive antidepressant use in bipolar disorder and its clinical correlates: An Asian psychotropic prescription patterns consortium study","volume":"17","author":"Hu","year":"2025","journal-title":"Asia-Pac Psychiatry Off J Pac Rim Coll Psychiatr"},{"key":"R162-20260420","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1176\/appi.ajp.2013.13020185","article-title":"The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders","volume":"170","author":"Pacchiarotti","year":"2013","journal-title":"Am J Psychiatry"},{"key":"R163-20260420","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0004867420979353","article-title":"The 2020 Royal Australian and New Zealand college of psychiatrists clinical practice guidelines for mood disorders","volume":"55","author":"Malhi","year":"2021","journal-title":"Aust N Z J Psychiatry"},{"key":"R164-20260420","doi-asserted-by":"crossref","first-page":"103480","DOI":"10.1016\/j.ajp.2023.103480","article-title":"Taiwan consensus on biological treatment of bipolar disorder during the acute, maintenance, and mixed phases: The 2022 update","volume":"82","author":"Cheng","year":"2023","journal-title":"Asian J Psychiatry"},{"key":"R165-20260420","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa064135","article-title":"Effectiveness of adjunctive antidepressant treatment for bipolar depression","volume":"356","author":"Sachs","year":"2007","journal-title":"N Engl J Med"},{"key":"R166-20260420","doi-asserted-by":"crossref","first-page":"79","DOI":"10.64719\/pb.4545","article-title":"Systematic review of second-generation antidepressant monotherapy for acute bipolar-II depression","volume":"55","author":"Elmosalamy","year":"2025","journal-title":"Psychopharmacol Bull"},{"key":"R167-20260420","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S2215-0366(16)30264-4","article-title":"Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabilizer or an atypical antipsychotic in acute bipolar depression: A systematic review and meta-analysis of randomized placebo-controlled trials","volume":"3","author":"McGirr","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"R168-20260420","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1399-5618.2009.00726.x","article-title":"The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders","volume":"11","author":"Tohen","year":"2009","journal-title":"Bipolar Disord"},{"key":"R169-20260420","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bdi.12612","article-title":"Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: A systematic review and meta-analysis","volume":"20","author":"Fornaro","year":"2018","journal-title":"Bipolar Disord"},{"key":"R170-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2023.04.013","article-title":"A systematic review of manic\/hypomanic and depressive switches in patients with bipolar disorder in naturalistic settings: The role of antidepressant and antipsychotic drugs","volume":"73","author":"Barbuti","year":"2023","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"R171-20260420","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jpsychires.2015.04.014","article-title":"Predictors of switch from depression to mania in bipolar disorder","volume":"66\u201367","author":"Niitsu","year":"2015","journal-title":"J Psychiatr Res"},{"key":"R172-20260420","doi-asserted-by":"crossref","first-page":"103413","DOI":"10.1016\/j.eclinm.2025.103413","article-title":"Switch to mania after acute antidepressant treatment for bipolar depression: A systematic review and network meta-analysis of randomized controlled trials","volume":"87","author":"Oliva","year":"2025","journal-title":"EClinicalMedicine"},{"key":"R173-20260420","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jad.2017.11.004","article-title":"Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression","volume":"227","author":"Olgiati","year":"2018","journal-title":"J Affect Disord"},{"issue":"Suppl 2","key":"R174-20260420","first-page":"26S","article-title":"What to do when your depressed patient develops mania","volume":"33","author":"Goldberg","year":"2016","journal-title":"Fed Pract"},{"key":"R175-20260420","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/YIC.0000000000000479","article-title":"Antidepressant emergent mood switch in major depressive disorder: Onset, clinical correlates and impact on suicidality","volume":"38","author":"Olgiati","year":"2023","journal-title":"Int Clin Psychopharmacol"},{"key":"R176-20260420","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1038\/s41380-020-00946-6","article-title":"Mood stabilizers and\/or antipsychotics for bipolar disorder in the maintenance phase: A systematic review and network meta-analysis of randomized controlled trials","volume":"26","author":"Kishi","year":"2021","journal-title":"Mol Psychiatry"},{"key":"R177-20260420","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1080\/14737175.2022.2161895","article-title":"Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper","volume":"22","author":"Sampogna","year":"2022","journal-title":"Expert Rev Neurother"},{"key":"R178-20260420","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40345-023-00322-7","article-title":"Why is lithium [not] the drug of choice for bipolar disorder? a controversy between science and clinical practice","volume":"12","author":"Kessing","year":"2024","journal-title":"Int J Bipolar Disord"},{"key":"R179-20260420","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/acps.13525","article-title":"The lithium paradox: Declining prescription of the gold standard treatment for bipolar disorder","volume":"147","author":"Bartoli","year":"2023","journal-title":"Acta Psychiatr Scand"},{"key":"R180-20260420","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ajp.2017.01.020","article-title":"Prevalence of metabolic syndrome and its clinical correlates among patients with bipolar disorder","volume":"26","author":"Kumar","year":"2017","journal-title":"Asian J Psychiatry"},{"key":"R181-20260420","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1017\/S2045796021000305","article-title":"Excess mortality and life-years lost in people with bipolar disorder: An 11-year population-based cohort study","volume":"30","author":"Chan","year":"2021","journal-title":"Epidemiol Psychiatr Sci"},{"key":"R182-20260420","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/acps.13715","article-title":"Cardiovascular mortality in bipolar disorder: Population-based cohort study","volume":"150","author":"Palj\u00e4rvi","year":"2024","journal-title":"Acta Psychiatr Scand"},{"key":"R183-20260420","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4103\/0253-7176.135377","article-title":"Co-morbidity in bipolar disorder: A retrospective study","volume":"36","author":"Munoli","year":"2014","journal-title":"Indian J Psychol Med"},{"key":"R184-20260420","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/0253-7176.112202","article-title":"Anxiety disorders in bipolar I mania: Prevalence, effect on illness severity, and treatment implications","volume":"35","author":"Das","year":"2013","journal-title":"Indian J Psychol Med"},{"key":"R185-20260420","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5498\/wjp.v9.i1.7","article-title":"Comorbidity of bipolar and anxiety disorders: An overview of trends in research","volume":"9","author":"Spoorthy","year":"2019","journal-title":"World J Psychiatry"},{"key":"R186-20260420","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00702-024-02876-x","article-title":"Untangling the complex relationship between bipolar disorder and anxiety: A comprehensive review of prevalence, prognosis, and therapy","volume":"132","author":"Wang","year":"2025","journal-title":"J Neural Transm (Vienna)"},{"key":"R187-20260420","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00406-006-0658-2","article-title":"Comorbidity of anxiety disorders in patients with remitted bipolar disorder","volume":"256","author":"Zutshi","year":"2006","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R188-20260420","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.5694\/j.1326-5377.2010.tb03892.x","article-title":"Comorbidities in bipolar disorder: Models and management","volume":"193","author":"Parker","year":"2010","journal-title":"Med J Aust"},{"key":"R189-20260420","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4088\/JCP.09r05815gre","article-title":"Treating nonspecific anxiety and anxiety disorders in patients with bipolar disorder: A review","volume":"72","author":"Rakofsky","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"R190-20260420","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jad.2022.09.057","article-title":"Anxiety in bipolar disorder: A review of publication trends","volume":"320","author":"Couillard Larocque","year":"2023","journal-title":"J Affect Disord"},{"key":"R191-20260420","doi-asserted-by":"crossref","first-page":"256","DOI":"10.9740\/mhc.2018.11.256","article-title":"Treatment of anxiety disorders in patients with comorbid bipolar disorder","volume":"8","author":"Ott","year":"2018","journal-title":"Ment Health Clin"},{"key":"R192-20260420","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cpr.2014.11.002","article-title":"Psychological therapy for anxiety in bipolar spectrum disorders: A systematic review","volume":"35","author":"Stratford","year":"2015","journal-title":"Clin Psychol Rev"},{"key":"R193-20260420","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00213-017-4642-5","article-title":"A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use","volume":"234","author":"Gao","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"R194-20260420","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4088\/JCP.v69n0413","article-title":"Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: A randomized, single-blind, pilot study","volume":"69","author":"Maina","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R195-20260420","doi-asserted-by":"crossref","first-page":"119348","DOI":"10.1016\/j.jad.2025.05.008","article-title":"Lurasidone for bipolar I depression with comorbid anxiety symptoms: Post-hoc-analysis of randomized, placebo-controlled studies","volume":"385","author":"Inoue","year":"2025","journal-title":"J Affect Disord"},{"key":"R196-20260420","doi-asserted-by":"crossref","first-page":"e3604","DOI":"10.17795\/ijpbs-3604","article-title":"Bipolar I and II disorders; A systematic review and meta-analysis on differences in comorbid obsessive-compulsive disorder","volume":"10","author":"Amerio","year":"2016","journal-title":"Iran J Psychiatry Behav Sci"},{"key":"R197-20260420","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/IJPSYM.IJPSYM_367_18","article-title":"Suicide risk in comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review","volume":"41","author":"Amerio","year":"2019","journal-title":"Indian J Psychol Med"},{"key":"R198-20260420","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4103\/0019-5545.192001","article-title":"Management of obsessive-compulsive disorder comorbid with bipolar disorder","volume":"58","author":"Kazhungil","year":"2016","journal-title":"Indian J Psychiatry"},{"key":"R199-20260420","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/indianjpsychiatry_1259_25","article-title":"Clinical practice guidelines for obsessive-compulsive disorder: 2025 update","volume":"68","author":"Arumugham","year":"2026","journal-title":"Indian J Psychiatry"},{"key":"R200-20260420","doi-asserted-by":"crossref","first-page":"e1531","DOI":"10.1002\/hsr2.1531","article-title":"Comparison of aripiprazole and risperidone effectiveness in treating obsessive-compulsive disorder in patients with bipolar disorder: Double-blind, randomized clinical trial","volume":"6","author":"Khorshidian","year":"2023","journal-title":"Health Sci Rep"},{"key":"R201-20260420","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1017\/S1092852921000572","article-title":"Is quetiapine effective for obsessive and compulsive symptoms in patients with bipolar disorder? A randomized, double-blind, placebo-controlled clinical trial","volume":"27","author":"Sahraian","year":"2022","journal-title":"CNS Spectr"},{"key":"R202-20260420","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/JCP.0000000000000651","article-title":"Memantine as an adjuvant treatment for obsessive compulsive symptoms in manic phase of bipolar disorder: A randomized, double-blind, placebo-controlled clinical trial","volume":"37","author":"Sahraian","year":"2017","journal-title":"J Clin Psychopharmacol"},{"key":"R203-20260420","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ajp.2019.05.015","article-title":"Add-on HD-tDCS for obsessive-compulsive disorder with comorbid bipolar affective disorder: A case series","volume":"43","author":"Parlikar","year":"2019","journal-title":"Asian J Psychiatry"},{"key":"R204-20260420","first-page":"13","article-title":"Bipolar disorder and comorbid borderline personality disorder: Patient characteristics and outcomes in US hospitals","volume":"55","author":"Patel","year":"2019","journal-title":"Med Kaunas Lith"},{"key":"R205-20260420","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/bdi.13465","article-title":"Comorbidity of bipolar disorder and borderline personality disorder: Phenomenology, course, and treatment considerations","volume":"26","author":"Temes","year":"2024","journal-title":"Bipolar Disord"},{"key":"R206-20260420","doi-asserted-by":"crossref","first-page":"725381","DOI":"10.3389\/fpsyt.2021.725381","article-title":"A feasibility study of the addition of STEPPS in outpatients with bipolar disorder and comorbid borderline personality features: Promises and pitfalls","volume":"12","author":"Riemann","year":"2021","journal-title":"Front Psychiatry"},{"key":"R207-20260420","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neubiorev.2021.01.017","article-title":"Comorbidity of ADHD and adult bipolar disorder: A systematic review and meta-analysis","volume":"124","author":"Schiweck","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"R208-20260420","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ajp.2012.12.011","article-title":"Comorbidity of attention-deficit\/hyperactivity disorder and bipolar disorder in North Indian clinic children and adolescents","volume":"6","author":"Sivakumar","year":"2013","journal-title":"Asian J Psychiatry"},{"key":"R209-20260420","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1399-5618.2006.00293.x","article-title":"Comorbidity of attention deficit hyperactivity disorder in juvenile bipolar disorder","volume":"8","author":"Jaideep","year":"2006","journal-title":"Bipolar Disord"},{"key":"R210-20260420","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajp.2018.05.015","article-title":"Relationship between bipolar disorder and attention deficit hyperkinetic disorder: An exploratory study","volume":"35","author":"Jhanda","year":"2018","journal-title":"Asian J Psychiatry"},{"key":"R211-20260420","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_647_23","article-title":"Prevalence and clinical correlates of co-morbid attention deficit hyperactivity disorder in euthymic adults with bipolar disorder: A cross-sectional study","volume":"65","author":"Mishra","year":"2023","journal-title":"Indian J Psychiatry"},{"key":"R212-20260420","first-page":"615","article-title":"Comorbid ADHD and bipolar disorder-An update","volume":"33","author":"Parker","year":"2025","journal-title":"Australas Psychiatry Bull R Aust N Z Coll Psychiatr"},{"key":"R213-20260420","first-page":"e86363","article-title":"Comprehensive review on association of bipolar disorder and substance abuse: Dual diagnosis and treatment approaches","volume":"17","author":"Bonner-Reid","year":"2025","journal-title":"Cureus"},{"key":"R214-20260420","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ajp.2016.02.010","article-title":"Bipolar spectrum disorders in substance use disorders","volume":"21","author":"Basu","year":"2016","journal-title":"Asian J Psychiatry"},{"key":"R215-20260420","doi-asserted-by":"crossref","first-page":"101835","DOI":"10.1016\/j.ajp.2019.10.015","article-title":"The link between bipolarity and substance use: A controlled clinic based study","volume":"47","author":"Gupta","year":"2020","journal-title":"Asian J Psychiatry"},{"key":"R216-20260420","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/00952990.2017.1292279","article-title":"Management of comorbid bipolar disorder and substance use disorders","volume":"43","author":"Salloum","year":"2017","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R217-20260420","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/15504263.2024.2328600","article-title":"Managing the dual diagnosis dilemma of bipolar disorder and substance abuse in clinical settings","volume":"20","author":"Samimi Ardestani","year":"2024","journal-title":"J Dual Diagn"},{"key":"R218-20260420","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pnpbp.2011.10.013","article-title":"Prevalence of metabolic syndrome in bipolar disorder: An exploratory study from North India","volume":"36","author":"Grover","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R219-20260420","doi-asserted-by":"crossref","first-page":"101876","DOI":"10.1016\/j.ajp.2019.101876","article-title":"Change in prevalence of metabolic syndrome in patients with bipolar disorder","volume":"47","author":"Grover","year":"2020","journal-title":"Asian J Psychiatry"},{"key":"R220-20260420","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jamapsychiatry.2025.2536","article-title":"GLP-1 receptor agonists for pharmacologically induced weight gain","volume":"82","author":"Zierhut","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"R221-20260420","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/ijnp\/pyz064","article-title":"The CINP guidelines on the definition and evidence-based interventions for treatment-resistant bipolar disorder","volume":"23","author":"Fountoulakis","year":"2020","journal-title":"Int J Neuropsychopharmacol"},{"key":"R222-20260420","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1192\/bjp.2018.257","article-title":"Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: Consensus definition","volume":"214","author":"Hidalgo-Mazzei","year":"2019","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"R223-20260420","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.2147\/NDT.S273503","article-title":"Treatment-resistant bipolar depression: Therapeutic trends, challenges and future directions","volume":"18","author":"Elsayed","year":"2022","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R224-20260420","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jad.2020.07.109","article-title":"The concept and management of acute episodes of treatment-resistant bipolar disorder: A systematic review and exploratory meta-analysis of randomized controlled trials","volume":"276","author":"Fornaro","year":"2020","journal-title":"J Affect Disord"},{"key":"R225-20260420","first-page":"178","article-title":"Treatment-resistant bipolar depression: Concepts and challenges for novel interventions","volume":"44","author":"Diaz","year":"2022","journal-title":"Rev Bras Psiquiatr Sao Paulo Braz 1999"},{"key":"R226-20260420","first-page":"1043","article-title":"Pramipexole augmentation for treatment-resistant unipolar and bipolar depression in the real world: A systematic review and meta-analysis","volume":"13","author":"Tundo","year":"2023","journal-title":"Life Basel Switz"},{"key":"R227-20260420","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jamapsychiatry.2024.1787","article-title":"Accelerated intermittent theta-burst stimulation and treatment-refractory bipolar depression: A randomized clinical trial","volume":"81","author":"Sheline","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"R228-20260420","doi-asserted-by":"crossref","first-page":"21m14022","DOI":"10.4088\/JCP.21m14022","article-title":"Treating insulin resistance with metformin as a strategy to improve clinical outcomes in treatment-resistant bipolar depression (the TRIO-BD Study): A randomized, quadruple-masked, placebo-controlled clinical trial","volume":"83","author":"Calkin","year":"2022","journal-title":"J Clin Psychiatry"},{"key":"R229-20260420","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpsychires.2020.02.026","article-title":"Clozapine in bipolar disorder: A systematic review and meta-analysis","volume":"125","author":"Delgado","year":"2020","journal-title":"J Psychiatr Res"},{"key":"R230-20260420","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/JCP.0000000000001693","article-title":"Clozapine use for bipolar disorder: An Asian psychotropic prescription patterns consortium study","volume":"43","author":"Loo","year":"2023","journal-title":"J Clin Psychopharmacol"},{"key":"R231-20260420","first-page":"100258","article-title":"Clozapine-related obsessive compulsive symptoms in an adolescent with bipolar disorder","volume":"4","author":"Cihanyurdu Erdem","year":"2025","journal-title":"Psychiatry Res Case Rep"},{"key":"R232-20260420","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jamapsychiatry.2025.1155","article-title":"FDA eliminates the clozapine REMS-what comes next?","volume":"82","author":"Kelly","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"R233-20260420","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1192\/j.eurpsy.2024.1816","article-title":"The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force","volume":"68","author":"Verdoux","year":"2025","journal-title":"Eur Psychiatry"},{"key":"R234-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.2024.150","article-title":"Clozapine monitoring requirements: Is it time for an update?","volume":"226","author":"Fernandez-Egea","year":"2025","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"R235-20260420","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S2215-0366(23)00343-7","article-title":"Evaluating the epidemiology of clozapine-associated neutropenia among people on clozapine across Australia and Aotearoa New Zealand: A retrospective cohort study","volume":"11","author":"Northwood","year":"2024","journal-title":"Lancet Psychiatry"},{"issue":"Suppl 1","key":"R236-20260420","first-page":"S362","article-title":"Research on electroconvulsive therapy in India: An overview","volume":"52","author":"Gangadhar","year":"2010","journal-title":"Indian J Psychiatry"},{"key":"R237-20260420","doi-asserted-by":"crossref","first-page":"103875","DOI":"10.1016\/j.ajp.2023.103875","article-title":"Electroconvulsive therapy in South Asia: Past, present, and future","volume":"92","author":"Menon","year":"2024","journal-title":"Asian J Psychiatry"},{"key":"R238-20260420","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/1570159X14666161017233642","article-title":"The role of electroconvulsive therapy (ECT) in bipolar disorder: Effectiveness in 522 patients with bipolar depression, mixed-state, mania and catatonic features","volume":"15","author":"Perugi","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"R239-20260420","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/PRA.0000000000000868","article-title":"Mood stabilizers, antipsychotics, and electroconvulsive therapy in patients with bipolar disorder during pregnancy and postpartum: A narrative review","volume":"31","author":"Cantilino","year":"2025","journal-title":"J Psychiatr Pract"},{"key":"R240-20260420","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/acps.12994","article-title":"ECT beyond unipolar major depression: Systematic review and meta-analysis of electroconvulsive therapy in bipolar depression","volume":"139","author":"Bahji","year":"2019","journal-title":"Acta Psychiatr Scand"},{"key":"R241-20260420","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jad.2010.05.008","article-title":"Comparison of electroconvulsive therapy (ECT) with or without anti-epileptic drugs in bipolar disorder","volume":"127","author":"Virupaksha","year":"2010","journal-title":"J Affect Disord"},{"key":"R242-20260420","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.psc.2016.04.004","article-title":"Adverse effects of electroconvulsive therapy","volume":"39","author":"Andrade","year":"2016","journal-title":"Psychiatr Clin North Am"},{"key":"R243-20260420","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_572_22","article-title":"Evidence from Indian studies on safety and efficacy of therapeutic transcranial magnetic stimulation across neuropsychiatric disorders- A systematic review and meta-analysis","volume":"65","author":"Tikka","year":"2023","journal-title":"Indian J Psychiatry"},{"key":"R244-20260420","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s11126-020-09822-6","article-title":"A systematic review and meta-analysis of randomized Sham-controlled trials of repetitive transcranial magnetic stimulation for bipolar disorder","volume":"91","author":"Tee","year":"2020","journal-title":"Psychiatr Q"},{"key":"R245-20260420","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpsychires.2025.07.021","article-title":"The efficacy and safety of theta burst stimulation for bipolar depression: A systematic review and meta-analysis","volume":"190","author":"Terao","year":"2025","journal-title":"J Psychiatr Res"},{"key":"R246-20260420","doi-asserted-by":"crossref","first-page":"105483","DOI":"10.1016\/j.neubiorev.2023.105483","article-title":"Comparing different non-invasive brain stimulation interventions for bipolar depression treatment: A network meta-analysis of randomized controlled trials","volume":"156","author":"Hsu","year":"2024","journal-title":"Neurosci Biobehav Rev"},{"key":"R247-20260420","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/JCP.0000000000001317","article-title":"A systematic review on the efficacy of intravenous racemic ketamine for bipolar depression","volume":"41","author":"Joseph","year":"2021","journal-title":"J Clin Psychopharmacol"},{"key":"R248-20260420","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/ipj.ipj_376_24","article-title":"A systematic scoping review of Indian literature on ketamine use for treating psychiatric disorders","volume":"34","author":"Singh","year":"2025","journal-title":"Ind Psychiatry J"},{"key":"R249-20260420","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3390\/brainsci13121672","article-title":"An update on the efficacy of single and serial intravenous ketamine infusions and esketamine for bipolar depression: A systematic review and meta-analysis","volume":"13","author":"Nunez","year":"2023","journal-title":"Brain Sci"},{"key":"R250-20260420","doi-asserted-by":"crossref","first-page":"e2899","DOI":"10.1002\/hup.2899","article-title":"Efficacy and safety of endoxifen in bipolar disorder: A systematic review","volume":"39","author":"Joseph","year":"2024","journal-title":"Hum Psychopharmacol"},{"key":"R251-20260420","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/bdi.13151","article-title":"Reply to Ghosh et al .1. Comments on Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder","volume":"24","author":"Ahmad","year":"2022","journal-title":"Bipolar Disord"},{"key":"R252-20260420","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/JCP.0000000000001643","article-title":"Endoxifen approval for bipolar disorder in India: A premature or a pragmatic decision?","volume":"43","author":"Gupta","year":"2023","journal-title":"J Clin Psychopharmacol"},{"key":"R253-20260420","first-page":"3684181","article-title":"Real-world long-term experience on endoxifen in bipolar disorder with psychotic symptoms","volume":"2022","author":"Thanvi","year":"2022","journal-title":"Case Rep Psychiatry"},{"key":"R254-20260420","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/brainsci8090168","article-title":"Gender differences and comorbidities in U.S. adults with bipolar disorder","volume":"8","author":"Patel","year":"2018","journal-title":"Brain Sci"},{"key":"R255-20260420","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11126-020-09838-y","article-title":"Gender differences in clinical characteristics and comorbidities in bipolar disorder: A study from South India","volume":"92","author":"Pillai","year":"2021","journal-title":"Psychiatr Q"},{"key":"R256-20260420","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jad.2023.07.060","article-title":"Gender differences in suicide among patients with bipolar disorder: A systematic review and meta-analysis","volume":"339","author":"Hu","year":"2023","journal-title":"J Affect Disord"},{"key":"R257-20260420","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1176\/appi.ajp.2010.09121816","article-title":"Longitudinal follow-up of bipolar disorder in women with premenstrual exacerbation: Findings from STEP-BD","volume":"168","author":"Dias","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"Suppl 2","key":"R258-20260420","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.4103\/0019-5545.161488","article-title":"Bipolar disorder in women","volume":"57","author":"Parial","year":"2015","journal-title":"Indian J Psychiatry"},{"key":"R259-20260420","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/bdi.12163","article-title":"Female vulnerability for thyroid function abnormality in bipolar disorder: Role of lithium treatment","volume":"16","author":"\u00d6zerdem","year":"2014","journal-title":"Bipolar Disord"},{"key":"R260-20260420","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/jwh.2019.7781","article-title":"Psychotropic treatment during pregnancy: Research synthesis and clinical care principles","volume":"29","author":"Betcher","year":"2020","journal-title":"J Womens Health"},{"key":"R261-20260420","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s40263-025-01202-7","article-title":"Management of bipolar disorder in pregnancy and postpartum: A clinicians\u2019 guide","volume":"39","author":"Bergink","year":"2025","journal-title":"CNS Drugs"},{"key":"R262-20260420","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4103\/ijp.ijp_407_21","article-title":"Pharmacological treatment of bipolar disorder in pregnancy: An update on safety considerations","volume":"54","author":"Singh","year":"2022","journal-title":"Indian J Pharmacol"},{"key":"R263-20260420","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jad.2024.12.102","article-title":"Antipsychotic use during pregnancy and outcomes in pregnant individuals and newborns","volume":"373","author":"Cho","year":"2025","journal-title":"J Affect Disord"},{"key":"R264-20260420","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41380-024-02697-0","article-title":"Safety of psychotropic medications in pregnancy: An umbrella review","volume":"30","author":"Fabiano","year":"2025","journal-title":"Mol Psychiatry"},{"key":"R265-20260420","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1176\/appi.ajp.2019.19030228","article-title":"Lithium exposure during pregnancy and the postpartum period: A systematic review and meta-analysis of safety and efficacy outcomes","volume":"177","author":"Fornaro","year":"2020","journal-title":"Am J Psychiatry"},{"key":"R266-20260420","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/acps.13797","article-title":"Gestational exposure to valproate and autism spectrum disorder or attention-deficit\/hyperactivity disorder in offspring: Systematic review and meta-analysis","volume":"151","author":"Andrade","year":"2025","journal-title":"Acta Psychiatr Scand"},{"key":"R267-20260420","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1535759719835353","article-title":"Comparative risk of major congenital malformations with 8 different antiepileptic drugs: A prospective cohort study of the EURAP registry","volume":"19","author":"Vossler","year":"2019","journal-title":"Epilepsy Curr"},{"key":"R268-20260420","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jamapsychiatry.2022.4109","article-title":"Association of in utero antipsychotic medication exposure with risk of congenital malformations in nordic countries and the US","volume":"80","author":"Huybrechts","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"R269-20260420","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s40263-022-00908-2","article-title":"Antipsychotic use during pregnancy and risk for gestational diabetes: A national register-based cohort study in Sweden","volume":"36","author":"Heinonen","year":"2022","journal-title":"CNS Drugs"},{"key":"R270-20260420","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S2215-0366(19)30092-6","article-title":"Childbirth and prevention of bipolar disorder: An opportunity for change","volume":"6","author":"Sharma","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"R271-20260420","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40345-018-0135-7","article-title":"Lithium during pregnancy and after delivery: A review","volume":"6","author":"Poels","year":"2018","journal-title":"Int J Bipolar Disord"},{"key":"R272-20260420","doi-asserted-by":"crossref","first-page":"493","DOI":"10.12740\/PP\/134254","article-title":"Use of psychotropic medications during lactation-practical guidelines for psychiatrists","volume":"56","author":"Kami\u0144ska-Sobczak","year":"2022","journal-title":"Psychiatr Pol"},{"key":"R273-20260420","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.euroneuro.2016.08.008","article-title":"Mood stabilizers and antipsychotics during breastfeeding: Focus on bipolar disorder","volume":"26","author":"Pacchiarotti","year":"2016","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"R274-20260420","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/JCP.0000000000001997","article-title":"Lactation-related side effects of aripiprazole: A study from perinatal psychiatry services in India","volume":"45","author":"Nanjundaswamy","year":"2025","journal-title":"J Clin Psychopharmacol"},{"key":"R275-20260420","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/apa.16444","article-title":"Lithium use during breastfeeding was safe in healthy full-term infants under strict monitoring","volume":"111","author":"Heinonen","year":"2022","journal-title":"Acta Paediatr"},{"key":"R277-20260420","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.neubiorev.2007.04.003","article-title":"Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena","volume":"31","author":"Post","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"key":"R278-20260420","doi-asserted-by":"crossref","first-page":"113995","DOI":"10.1016\/j.psychres.2021.113995","article-title":"Residual symptoms in bipolar disorders: Findings from the bipolar Disorder course and outcome study from India (BiD-CoIN study)","volume":"302","author":"Grover","year":"2021","journal-title":"Psychiatry Res"}],"container-title":["Indian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/indianjpsychiatry_1186_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:27:52Z","timestamp":1786724872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/indianjpsychiatry_1186_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":271,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/indianjpsychiatry_1186_25","relation":{},"ISSN":["0019-5545","1998-3794"],"issn-type":[{"value":"0019-5545","type":"print"},{"value":"1998-3794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-11-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}